Infant botulism is rare but remains the most common form of botulism in the United States. The national rate is roughly 2 to 3 cases per 100,000 live births per year, which translates to about 100 to 150 confirmed cases annually. While those numbers are small, infant botulism accounts for about 65% of all botulism cases reported in the U.S., making it far more frequent than the foodborne or wound forms most people picture when they hear the word “botulism.”
Why Babies Are Vulnerable
Adults swallow tiny amounts of botulism-causing spores all the time without getting sick. Their gut bacteria crowd out the spores before they can grow. Infants don’t have that protection yet. A baby’s digestive tract is still being colonized by helpful bacteria, and until that ecosystem matures, swallowed spores can settle in, germinate, and produce toxin directly inside the intestine.
Research on affected infants shows their gut bacteria lag behind in development. Healthy babies gradually build up diverse bacterial families that, by around age one, outnumber the early-life bacteria that dominate the newborn gut. In infants who develop botulism, that shift is delayed, leaving a less competitive environment where toxin-producing bacteria can gain a foothold. This is the same basic principle behind why adults sometimes develop a similar intestinal infection after surgery, gut disorders, or heavy antibiotic use: anything that disrupts the normal bacterial community can open the door.
Peak Age and Risk Window
The typical patient is about 4 months old. Cases have been documented as early as 1 week and as late as 60 weeks (just over a year), but the median age at diagnosis is 16 weeks. By the time most children reach their first birthday, their gut bacteria are diverse and established enough to fend off spore colonization, which is why the risk drops sharply after 12 months.
Geography Matters More Than You’d Think
Infant botulism is not evenly distributed across the country. Certain regions see dramatically higher rates, and the difference comes down to soil. A 20-year study identified a stretch of 17 counties across Delaware, Maryland, New Jersey, New York, and Pennsylvania where the incidence was nearly seven times greater than in surrounding areas. Within that zone, rates ranged from 6 to 48 cases per 100,000 live births, compared to just 2.6 per 100,000 in neighboring counties of the same states.
The counties with the highest rates included Montgomery County, PA (48.1 per 100,000), Bucks County, PA (45.7), Hunterdon County, NJ (44.5), and Cecil County, MD (38.2). Researchers found that cases were strongly linked to specific soil types, particularly certain clay soils and soils with layers that restrict water flow. Spores persist in soil for years, and infants can encounter them through dust tracked indoors, outdoor play surfaces, or anything that contacts contaminated ground.
Honey and Other Sources
Honey is the one source most parents have heard about, and the warning is real. Surveys of honey samples from around the world, spanning 1978 to 2023, found botulism spores in about 4% of samples tested. That’s a low percentage, but since even a tiny number of spores can colonize an infant’s gut, the CDC recommends no honey of any kind before 12 months. That includes honey added to food, water, formula, or pacifiers, and it applies to both raw and pasteurized honey (pasteurization doesn’t destroy these spores).
That said, honey is identified as the source in only a minority of cases. Most of the time, the exact source is never pinpointed. The spores exist naturally in soil and dust, so many infants are likely exposed through everyday environmental contact rather than a specific food.
Symptoms to Recognize
Constipation is usually the first sign, sometimes appearing days before other symptoms. Parents often notice the baby hasn’t had a bowel movement in three or more days, which on its own isn’t unusual for infants but becomes significant in context with what follows.
After constipation, the progression typically includes poor feeding, a weak or altered cry, drooping eyelids, and a flattened facial expression. The baby may lose their suck and gag reflexes, appear increasingly floppy, and have difficulty controlling their head. In severe cases, breathing becomes labored. The pattern of descending weakness, starting at the head and face and moving downward, is characteristic. Because the onset is gradual, sometimes over several days, parents may initially attribute the changes to fussiness or a mild illness before the broader picture becomes clear.
Treatment and Recovery
The survival rate for infant botulism is between 98% and 100% with modern care, so while the diagnosis is frightening, outcomes are overwhelmingly good. The key treatment is an antitoxin specifically designed for infants. In a clinical trial published in the New England Journal of Medicine, infants who received this treatment spent an average of 2.6 weeks in the hospital, compared to 5.7 weeks for those who didn’t, cutting the stay by more than half. Hospital charges dropped by an average of $88,600 per patient.
Recovery still takes time. The toxin must clear the body, and nerve function returns gradually. Some babies need breathing support or tube feeding during the worst of the illness. Most make a full recovery, though the weeks in the hospital can be an intense experience for families. Mild residual weakness or feeding difficulties may linger for a short period after discharge, but long-term complications are uncommon.
Putting the Numbers in Perspective
For any individual baby, the odds of developing infant botulism are very low. Even in the highest-risk counties identified in the U.S., fewer than 1 in 2,000 infants were affected over a 20-year period. Nationally, the figure is closer to 1 in 40,000 to 50,000 births. The condition is serious enough to warrant basic precautions, particularly avoiding honey before age one and being aware of the early signs, but it is not something most parents will ever encounter firsthand.